| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
Denis Angioletti
BRD | Director/Board Member | 58 | 01/01/2020 |
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -98.73% | - | - | 92.63K | ||
| -1.12% | -5.96% | +48.15% | +155.71% | 1,028B | ||
| -1.16% | -4.76% | +61.66% | +57.70% | 611B | ||
| +1.61% | -2.17% | +32.66% | +83.39% | 432B | ||
| +0.98% | -1.40% | +29.49% | +23.12% | 323B | ||
| -0.34% | -3.10% | +27.00% | +43.66% | 277B | ||
| +1.63% | -11.76% | +19.72% | +23.20% | 257B | ||
| +3.39% | +2.29% | -23.68% | -38.33% | 217B | ||
| +1.05% | -2.30% | +22.88% | +57.76% | 192B | ||
| +2.03% | -2.35% | +21.61% | +71.18% | 161B | ||
| Average | +0.86% | -5.24% | +26.61% | +53.04% | 388.7B | |
| Weighted average by Cap. | +0.27% | -5.52% | +36.05% | +77.51% |
Employees
4
Sector
Pharmaceuticals
















